Orthofix Medical Inc. (OFIX) stock
OFIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 23
$6.61−0.06 (-0.90%)
Close on Nov 18, 2026Market cap $269.24MP/E –Yield –
Orthofix Medical free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Orthofix Medical's free cash flow for the twelve months ending Jun 30, 2026 was -$27.82M, down 6135.6% year over year. For fiscal 2025 it was -$1.28M. The highest annual figure on record is $58.79M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.28M | – |
| FY2024 | Dec 31, 2024 | -$9.09M | – |
| FY2023 | Dec 31, 2023 | -$107.80M | – |
| FY2022 | Dec 31, 2022 | -$34.70M | -5128.7% |
| FY2021 | Dec 31, 2021 | $690.00K | -98.8% |
| FY2020 | Dec 31, 2020 | $58.79M | +351.0% |
| FY2019 | Dec 31, 2019 | $13.04M | -64.1% |
| FY2018 | Dec 31, 2018 | $36.33M | +49.4% |
| FY2017 | Dec 31, 2017 | $24.31M | -43.0% |
| FY2016 | Dec 31, 2016 | $42.64M | +159.8% |
| FY2015 | Dec 31, 2015 | $16.41M | -50.4% |
| FY2014 | Dec 31, 2014 | $33.10M | -21.7% |
| FY2013 | Dec 31, 2013 | $42.26M | – |
| FY2012 | Dec 31, 2012 | -$17.83M | -144.8% |
| FY2011 | Dec 31, 2011 | $39.77M | +141.5% |
| FY2010 | Dec 31, 2010 | $16.47M | -44.5% |
| FY2009 | Dec 31, 2009 | $29.67M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$18.87M | -516.6% |
| Q1 FY2026 | Mar 31, 2026 | -$28.27M | – |
| Q4 FY2025 | Dec 31, 2025 | $16.82M | +10.7% |
| Q3 FY2025 | Sep 30, 2025 | $2.50M | -57.4% |
| Q2 FY2025 | Jun 30, 2025 | $4.53M | – |
| Q1 FY2025 | Mar 31, 2025 | -$25.13M | – |
| Q4 FY2024 | Dec 31, 2024 | $15.20M | – |
| Q3 FY2024 | Sep 30, 2024 | $5.86M | – |
| Q2 FY2024 | Jun 30, 2024 | -$732.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$29.41M | – |
| Q4 FY2023 | Dec 31, 2023 | -$23.05M | – |
| Q3 FY2023 | Sep 30, 2023 | -$21.40M | – |
| Q2 FY2023 | Jun 30, 2023 | -$17.87M | – |
| Q1 FY2023 | Mar 31, 2023 | -$45.49M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.65M | -183.8% |
| Q3 FY2022 | Sep 30, 2022 | -$6.39M | -263.6% |
| Q2 FY2022 | Jun 30, 2022 | -$10.62M | – |
| Q1 FY2022 | Mar 31, 2022 | -$13.04M | – |
| Q4 FY2021 | Dec 31, 2021 | $5.55M | -69.9% |
| Q3 FY2021 | Sep 30, 2021 | $3.91M | -79.2% |
| Q2 FY2021 | Jun 30, 2021 | -$6.85M | -151.3% |
| Q1 FY2021 | Mar 31, 2021 | -$1.92M | -123.5% |
| Q4 FY2020 | Dec 31, 2020 | $18.43M | +175.8% |
| Q3 FY2020 | Sep 30, 2020 | $18.82M | +147.5% |
| Q2 FY2020 | Jun 30, 2020 | $13.36M | +201.4% |
| Q1 FY2020 | Mar 31, 2020 | $8.18M | – |
| Q4 FY2019 | Dec 31, 2019 | $6.68M | -60.9% |
| Q3 FY2019 | Sep 30, 2019 | $7.60M | -36.6% |
| Q2 FY2019 | Jun 30, 2019 | $4.43M | -67.5% |
| Q1 FY2019 | Mar 31, 2019 | -$5.68M | – |
| Q4 FY2018 | Dec 31, 2018 | $17.08M | -35.8% |
| Q3 FY2018 | Sep 30, 2018 | $11.99M | +28.1% |
| Q2 FY2018 | Jun 30, 2018 | $13.64M | +363.5% |
| Q1 FY2018 | Mar 31, 2018 | -$6.39M | – |
| Q4 FY2017 | Dec 31, 2017 | $26.62M | +54.9% |
| Q3 FY2017 | Sep 30, 2017 | $9.36M | -31.6% |
| Q2 FY2017 | Jun 30, 2017 | $2.94M | – |
| Q1 FY2017 | Mar 31, 2017 | -$14.62M | – |
| Q4 FY2016 | Dec 31, 2016 | $17.18M | – |
| Q3 FY2016 | Sep 30, 2016 | $13.69M | – |
See a number that looks wrong?